Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $2,565 - $2,923
-10 Reduced 0.13%
7,624 $2.12 Million
Q4 2022

Feb 09, 2023

SELL
$252.44 - $306.72 $19,942 - $24,230
-79 Reduced 1.02%
7,634 $2.11 Million
Q3 2022

Nov 07, 2022

SELL
$194.69 - $268.46 $12,265 - $16,912
-63 Reduced 0.81%
7,713 $2.06 Million
Q2 2022

Aug 02, 2022

SELL
$187.54 - $223.02 $5,626 - $6,690
-30 Reduced 0.38%
7,776 $1.59 Million
Q1 2022

Apr 28, 2022

BUY
$193.77 - $244.14 $94,947 - $119,628
490 Added 6.7%
7,806 $1.64 Million
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $3,806 - $4,892
-17 Reduced 0.23%
7,316 $1.76 Million
Q3 2021

Nov 05, 2021

BUY
$282.99 - $369.05 $2,829 - $3,690
10 Added 0.14%
7,333 $2.08 Million
Q2 2021

Jul 27, 2021

BUY
$259.0 - $414.71 $33,929 - $54,327
131 Added 1.82%
7,323 $2.54 Million
Q1 2021

May 07, 2021

BUY
$242.95 - $284.63 $114,672 - $134,345
472 Added 7.02%
7,192 $2.01 Million
Q4 2020

Feb 05, 2021

SELL
$236.26 - $355.63 $6,142 - $9,246
-26 Reduced 0.39%
6,720 $1.63 Million
Q3 2020

Nov 03, 2020

BUY
$264.77 - $305.71 $9,002 - $10,394
34 Added 0.51%
6,746 $1.91 Million
Q2 2020

Jul 29, 2020

BUY
$258.66 - $342.55 $795,896 - $1.05 Million
3,077 Added 84.65%
6,712 $1.8 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $257,558 - $326,716
958 Added 35.79%
3,635 $1.15 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $10,525 - $11,602
-48 Reduced 1.76%
2,677 $626,000
Q1 2019

Apr 11, 2019

BUY
$216.71 - $338.96 $590,534 - $923,666
2,725 New
2,725 $644,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Malaga Cove Capital, LLC Portfolio

Follow Malaga Cove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.